-
2121
Progress in Managing Heart Failure: an in-depth Review of Sacubitril/Valsartan Combination Therapy
Published 2024-04-01“…Numerous significant clinical trials have investigated the drug’s safety and efficacy in treating individuals with heart failure and a failing systemic right ventricle. …”
Get full text
Article -
2122
Cytokine Reduction in the Treatment of Joint Conditions
Published 1994-01-01“…Pharmacologic regulation of IL-1 and TNFα remain primary targets for treatment of arthritis, and results of early clinical trials are promising. However, the results of long-term clinical trials will be required to support the value of anti-cytokine therapy in treatment of arthritis.…”
Get full text
Article -
2123
A Photothermal Modelling Approach for Micro-LED Arrays in Wireless Optogenetics
Published 2024-01-01“…However, as optogenetics moves towards clinical trials, combinatorial photostimulation based on arrays of LED light sources has emerged. …”
Get full text
Article -
2124
An expert perspective on diversity-oriented standards for assessing sex and gender in clinical research
Published 2025-01-01“…Experts rated the importance and practicality of assessing these concepts in clinical trials and evaluated terms for suitability and comprehension. …”
Get full text
Article -
2125
Immunotherapeutic Approaches in Triple-Negative Breast Cancer: State of the Art and Future Perspectives
Published 2020-01-01“…Recently, immunotherapy is being extensively explored in TNBC and clinical trials have shown promising results. In this article, we tried to explain the rationale and mechanisms of targeting the immune system in TNBC, to report the results from recent clinical trials that put immunotherapy as a new standard of care in TNBC in addition to ongoing trials and future directions in the next decade.…”
Get full text
Article -
2126
Benefits from Long-Term Treatment in Irritable Bowel Syndrome
Published 2012-01-01“…Long-term treatment should be reserved to diagnosed IBS patients with recurrent symptoms. Clinical trials with stabilized therapies and new active treatments showed an improvement of the symptoms over placebo that is often time-dependent but with high relapse rates (around 40%–50% when stopping treatment). …”
Get full text
Article -
2127
Hypoxia-Inducible Factor-1 as a Therapeutic Target in Endometrial Cancer Management
Published 2010-01-01“…Further work is needed to identify selective HIF-1 inhibitors and to translate these into clinical trials.…”
Get full text
Article -
2128
Retroperitoneal Lymph Node Dissection as Primary Treatment for Metastatic Seminoma
Published 2018-01-01“…To better determine if RPLND can be recommended as a primary treatment option, two prospective clinical trials (SEMS and PRIMETEST) are underway. This review will examine the literature, discuss the benefits/limitations of RPLND, and compare the methodologies of the two ongoing clinical trials.…”
Get full text
Article -
2129
The Critical Management of Spinal Cord Injury: A Narrative Review
Published 2024-12-01“…New neuroprotective agents currently in clinical trials show promising results and should be further studied to determine their role in acute SCI management.…”
Get full text
Article -
2130
Peroxisome proliferator–activated receptor delta and liver diseases
Published 2025-02-01“…This review provides an overview of PPAR-delta’s function and biology in the liver, examines its kinetics and therapeutic potential across different liver diseases, and discusses the current status of clinical trials involving its agonists.…”
Get full text
Article -
2131
Metformin versus insulin in gestational diabetes mellitus: a systematic review
Published 2025-01-01“…Data sources: This article consists of a systematic review of randomized clinical trials. The searches were carried out on MEDLINE including 7 studies, between 2010 to 2021. …”
Get full text
Article -
2132
Inflammation in Heart Failure: Mechanisms and Therapeutic Strategies
Published 2025-01-01“…However, almost all clinical trials on the anti-inflammatory treatment of HF have not indicated improved clinical outcomes, and some have reported deterioration of the condition, possibly because of limited understanding of the specific role of inflammation in HF. …”
Get full text
Article -
2133
Resurgence of blackwater fever among children in sub-Saharan Africa: a scoping review protocol
Published 2022-07-01Get full text
Article -
2134
Omeprazole: Inhibiting the Final Common Pathway to Acid Secretion - The Acid Pump
Published 1989-01-01“…Omeprnzole has been shown in clinical trials to be the first consistently effective treatment of erosive/ulcerative reflux esophagitis. …”
Get full text
Article -
2135
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Published 2021“…This review examines the limited number of clinical trials published, to date that have deployed this therapy and explores clinical trials in progress for the treatment of COVID-19.…”
Get full text
Article -
2136
PD-1/PD-L1 inhibitors related adverse events: A bibliometric analysis from 2014 to 2024
Published 2025-12-01“…Biomarker research and multi-phase clinical trials are likely to be key areas of focus in future studies.…”
Get full text
Article -
2137
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Published 2023“…This review examines the limited number of clinical trials published, to date that have deployed this therapy and explores clinical trials in progress for the treatment of COVID-19…”
Get full text
Article -
2138
Phospholipid derived mediators and glomerulonephritis
Published 1993-01-01“…A case can be made for clinical trials of PAF, leukotriene and thromboxane antagonists. …”
Get full text
Article -
2139
Translational Science in Vascular Aging: From Bench to Bedside—Insights from a VascAgeNet Roundtable
Published 2024-09-01“…Pragmatic and registry-based clinical trials offer viable alternatives to traditional randomized controlled trials, facilitating real-world applicability. …”
Get full text
Article -
2140
Impairment of cocaine-mediated behaviours in mice by clinically relevant Ras-ERK inhibitors
Published 2016-08-01“…Furthermore, a screening of small therapeutics currently in clinical trials for cancer therapy revealed PD325901 as a brain-penetrating drug that blocks ERK signalling in the nanomolar range. …”
Get full text
Article